Clinical Research Support Unit

THE TISCH CANCER INSTITUTE

To promote academic excellence and equitable care for all, The Tisch Cancer Institute is dedicated to supporting diversity, equity, and inclusion in the cancer workforce. We aim to foster an inclusive culture and maintain a nurturing and supportive environment that allows all members of our community to thrive and contribute towards achieving equity in science and medicine.

All cancer clinical trials are monitored according to guidelines in The Tisch Cancer Institute’s Data and Safety Monitoring Plan. A formal Data and Safety Monitoring Committee ensures that the Institute’s investigator-initiated clinical trials are compliant with the Data and Safety Monitoring Plan. The Committee reviews, on an ongoing basis, data regarding safety and efficacy from active investigator-initiated clinical trials deemed high-risk to ensure the safety of study participants.

Clinical trials at The Tisch Cancer Institute include significant percentages of patients representing minority populations and women, as well as pediatric and elderly patients.

Research Consortia

The Clinical Research Support Unit currently supports three research consortia:

MAGIC-Mount Sinai Acute Graft-Versus-Host-Disease International Consortium. A consortium of 25 stem cell transplant centers in the United States, Canada, Europe, and Asia that collaborate on clinical trials to prevent and treat acute Graft-Versus-Host-Disease. For more information, contact Rachel Young.
The Myeloproliferative Neoplasms Research Consortium. An interactive collaboration between laboratory scientists, clinical scientists, and a biostatistics team, who coordinate to develop and evaluate treatments to improve the survival of patients with myeloproliferative neoplasms. The Consortium has investigators across 11 institutions in the United States and Canada. For more information, contact Mikaela Dougherty.

Disease Specific Research Teams

Clinical research nurses and coordinators have regular assignments with investigators and disease-specific research teams to build expertise in particular areas of oncology. For more information, please email crsu@mssm.edu.

For Investigators

The Tisch Cancer Institute’s Clinical Research Support Unit retains oversight of all cancer-related clinical research conducted in the Mount Sinai Health System. Our research and trials are required to be reviewed by the Protocol Review and Monitoring Committee. Approved projects are then reviewed by the Icahn School of Medicine at Mount Sinai Institutional Review Board. In collaboration with the Office of Research Services, the Clinical Research Support Unit facilitates research by providing both resources and expertise to The Tisch Cancer Institute Investigators.

Careers

The field of clinical research provides opportunities to make meaningful contributions to science that powerfully impact the lives of cancer patients. At The Tisch Cancer Institute, we are dedicated to developing a sustainable cancer-focused clinical trial workforce, and we regularly seek promising individuals to join careers.mountsinai.org our talented team. We also educate the next generation of clinical research professionals through our Master of Science in Clinical Research and our Clinical Research Training Program Certificate.